首页> 外文期刊>American Journal of Hypertension >Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia
【24h】

Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia

机译:小剂量阿托伐他汀对高血压和高胆固醇血症患者的动脉僵硬度和主动脉主动脉压力增高的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background Experimental and clinical data suggest that statins exert anti-inflammatory and antiproliferative actions on vasculature beyond their lipid-lowering properties. Whether these pleiotropic effects of statins translate into a beneficial effect on arterial stiffness is not clear. This study aimed to evaluate the potential effects of low-dose atorvastatin treatment on arterial stiffness and central arterial pressure waveforms in patients with mild hypertension and hypercholesterolemia. Methods In a double-blind, randomized, placebo-controlled fashion, 50 hypertensive and hypercholesterolemic patients were allocated to receive 10mg of atorvastatin or placebo for 26 weeks. Arterial stiffness was assessed by aortic pulse-wave velocity (PWV) using a Sphygmocor device. Central arterial pressure waveform parameters were estimated by radial artery applanation tonometry. Heart rate-adjusted augmentation index (AIx(75)) was used as measure of wave reflections.RESULTSAt study end, aortic PWV (9.0±1.5 vs. 10.9±2.6 m/sec; P<0.001) and AIx(75) (24.9% ± 9.7% vs 28.8% ± 11.8%; P < 0.001) were significantly lower in the atorvastatin group than that placebo group. Furthermore, decreases in central aortic systolic blood pressure and pulse pressure were evident at study-end with atorvastatin but not with placebo (130±8 vs. 138±6mm Hg, P < 0.001; 48±7 vs. 53±6mm Hg, P < 0.05, respectively). Atorvastatin-induced reductions in aortic PWV during follow-up showed significant associations with changes in AIx(75) and central aortic systolic blood pressure and pulse pressure. Conclusions This study shows that low-dose atorvastatin treatment improves arterial stiffness and exerts a reduction on central aortic pressures. These effects may represent a potential mechanism of cardiovascular risk reduction observed with statin use. Clinical Trial Registration clinicaltrials.gov Database Identifier Number:
机译:背景技术实验和临床数据表明,他汀类药物除了具有降血脂作用外,还对血管具有抗炎和抗增殖作用。他汀类药物的这些多效性作用是否转化为对动脉僵硬度的有益作用尚不清楚。这项研究旨在评估低剂量阿托伐他汀对轻度高血压和高胆固醇血症患者的动脉僵硬度和中央动脉压波形的潜在影响。方法以双盲,随机,安慰剂对照的方式,将50名高血压和高胆固醇血症患者分配为接受10mg阿托伐他汀或安慰剂治疗26周。使用Sphygmocor装置通过主动脉脉搏波速度(PWV)评估动脉僵硬度。通过radial动脉扁平眼压计估计中央动脉压波形参数。心率调整后的增强指数(AIx(75))用于测量波反射。结果研究结束时,主动脉PWV(9.0±1.5对10.9±2.6 m / sec; P <0.001)和AIx(75)(24.9在阿托伐他汀组中,%±9.7%和28.8%±11.8%; P <0.001)显着低于安慰剂组。此外,在研究结束时,使用阿托伐他汀可明显降低中心主动脉收缩压和脉压,而使用安慰剂则无明显降低(130±8 vs. 138±6mm Hg,P <0.001; 48±7 vs. 53±6mm Hg,P分别<0.05)。阿托伐他汀在随访期间引起的主动脉PWV降低显示与AIx(75)的变化以及主动脉中央收缩压和脉压显着相关。结论该研究表明,小剂量阿托伐他汀治疗可改善动脉僵硬度并降低中心主动脉压。这些作用可能代表使用他汀类药物所观察到的降低心血管风险的潜在机制。临床试验注册临床试验.gov数据库标识符:

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号